Downers Grove, IL – Coventry recently released part two of its Annual Drug Trends Series. In part two of the series Coventry provides analysis on the trends experienced within its combined in- and out-of-network channels.
Highlights from this section include:
- 8 of the top 10 therapeutic classes experienced decreases
- Opioids decreased over 2% points from 2017
- Compounds fell out of the top 10 classes in both utilization and cost
Each part in the series is accompanied by a deeper dive into various related topics to address specific trends highlighted in the drug trend series. Part two’s accompanying piece explores utilization & cost metrics for Brand and Generic drugs.
Coventry noted that in 2018, First Script realized a 0.6% increase in generic utilization1. Generic medications contain the same active ingredient and approved indications as their brand name counterparts. An increase of 0.6% might not seem like a lot; however, when the difference in cost per script is considered, it is easy to see why a shift in favor of generic use is a win and can be a big cost saver.
First Script’s average cost per script for a generic medication in 2018 was about $104. This is much lower than the 2018 average cost per script for brand-only and brand w/generic available medications ($584 and $355 respectively).
The infographic and deeper dive post can be found here: Coventry 2018 Drug Trend Series Part 2
Coventry is a WorkCompWire ad partner.
This is not a paid placement.